Main points
-
More than 22,000 bottles of Icosapent Ethyl, used to lower triglycerides, have been recalled.
-
The recall is due to oxidation issues, which can cause unexpected side effects.
-
Check code and expiration date; return affected bottles for refund or replacement.
According to the U.S. Food and Drug Administration (FDA), 22,896 bottles of the cholesterol medication sold nationwide are being actively recalled. This is due to chemical issues that can lead to consumer health issues.
The affected prescription drugs are 120 vials of Icosapent Ethyl manufactured by Softgel Healthcare and distributed by Zydus Pharmaceuticals. This drug is often used with statins to lower high triglyceride levels and reduce the risk of serious cardiovascular events, including heart attack.
The lot numbers and dates affected by the recalled drugs include lot number “S2520304” or “S2520333,” with an expiration date of “2/28/2027,” and lot number “S2540186,” with an expiration date of “4/30/2027.” If your prescription matches the recall information, throw it away or return it to the pharmacy for a refund or replacement.
The recall was announced after an oxidation issue was discovered, which was caused by “leakage of the contents of the eicosapent ethyl capsules.” “Use of the affected products may result in inconsistent therapeutic effects and increase the potential for gastrointestinal side effects in some patients,” the FDA said. The recall is classified as Class II, meaning taking the pills may cause temporary, non-serious health problems. If you have any medical questions or concerns after taking the recalled drugs, please contact your healthcare provider.
For questions about this recall, please call FDA: 1-888-INFO-FDA (1-888-463-6332).
Read the original article on EatWell
